Experiment 964324

Worktypes

ANTICANCER AND/OR CYTOTOXICITY MARKER CODEPATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

AVELLANIN B

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismEmpty organism
CitationISHII,S: SATO,Y: WATABE,H: YAMAMOTO,H: SHOMURA,T: SEZAKI,M: INOUE,S:. (1990). ENHANCEMENT OF ANTICANCER AGENTS BY AVELLANIN A OR B.. ()
Amount utilized
Compound isolated
DiseaseTHIS ABSTRACT REPORTS THE USE OF AVELLANIN B AS AN ENHANCER OF ANTICANCER DRUGS AGAINST MULTIDRUG-RESISTANT CANCER CELLS. NO SPECIFIC DATA ARE GIVEN.
Dose amount1.0 MCG
Number2
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED